A Critical Evaluation of T_m(FTIR) Measurements of High-Concentration IgG₁ Antibody Formulations as a Formulation Development Tool

By Matheus Susanne   Mahler Hanns-Christian   Friess Wolfgang  

Pharmaceutical Research, Vol. 23, Iss. 7, 2006-07 ,pp. : 1617-1627

Springer Publishing Company

Access to resources Recommend Favorite

High Concentration Formulation Studies of an IgG2 Antibody Using Small Angle X-ray Scattering

By Mosbæk Charlotte  

Pharmaceutical Research, Vol. 29, Iss. 8, 2012-08 ,pp. : 2225-2235

Springer Publishing Company

Access to resources Recommend Favorite

Phase Separation of an IgG1 Antibody Solution under a Low Ionic Strength Condition

By Nishi Hirotaka   Miyajima Makoto   Nakagami Hiroaki   Noda Masanori   Uchiyama Susumu   Fukui Kiichi  

Pharmaceutical Research, Vol. 27, Iss. 7, 2010-07 ,pp. : 1348-1360

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab: an IgG1 monoclonal antibody for the treatment of epidermal growth factor receptor-expressing tumours

By Humblet Yves  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1621-1633

Informa Healthcare

Access to resources Recommend Favorite

Effect of pH and Excipients on Structure, Dynamics, and Long-Term Stability of a Model IgG1 Monoclonal Antibody upon Freeze-Drying

By Park Jihea   Nagapudi Karthik   Vergara Camille   Ramachander Ranjini   Laurence Jennifer   Krishnan Sampathkumar  

Pharmaceutical Research, Vol. 30, Iss. 4, 2013-04 ,pp. : 968-984

Springer Publishing Company

Access to resources Recommend Favorite